Antibody-drug conjugate effective, less toxic for stage 1 HER2+ breast cancer

[News]

A year of treatment with a medicine made of an antibody and chemotherapy drug has proven highly effective in preventing stage 1 HER2-positive breast cancer from recurring in patients, a team led by Dana-Farber Cancer Institute researchers has found.

More... (https://www.news-medical.net/news/20240628/Antibody-drug-conjugate-effective-less-toxic-for-stage-1-HER22b-breast-cancer.aspx)